Leuprolyn Depot 3.75 mg Injection 1's belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis. Additionally, it is also used to treat precocious puberty (early puberty) in children. Leuprolyn Depot 3.75 mg Injection 1's is used in combination with other medicines to treat anaemia caused by uterine fibroids.

Leuprolyn Depot 3.75 mg Injection 1's contains Leuprolide acetate, which is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell growth in prostate cancer and helps treat endometriosis.

Leuprolyn Depot 3.75 mg Injection 1's will be administered by a healthcare professional. The common side effects of Leuprolyn Depot 3.75 mg Injection 1's include hot flashes, decreased sexual interest, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Avoid taking Leuprolyn Depot 3.75 mg Injection 1's if you are pregnant or breastfeeding. Both women and men using Leuprolyn Depot 3.75 mg Injection 1's should use effective contraception. Leuprolyn Depot 3.75 mg Injection 1's may affect fertility, hence discuss with your doctor if you have any plans to start a family in the future. Leuprolyn Depot 3.75 mg Injection 1's is not recommended for children below two years of age. Leuprolyn Depot 3.75 mg Injection 1's may cause dizziness, hence drive only if you are alert.

Leuprolyn Depot 3.75 mg Injection 1's contains Leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Leuprolyn Depot 3.75 mg Injection 1's is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Leuprolyn Depot 3.75 mg Injection 1's works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Leuprolyn Depot 3.75 mg Injection 1's reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helping in endometriosis.

If you are allergic to Leuprolyn Depot 3.75 mg Injection 1's or any other medicines, please tell your doctor. Leuprolyn Depot 3.75 mg Injection 1's is not indicated for use in pregnancy and breastfeeding women. If you are using Leuprolyn Depot 3.75 mg Injection 1's, make sure to use reliable forms of contraception. Leuprolyn Depot 3.75 mg Injection 1's may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Leuprolyn Depot 3.75 mg Injection 1's is not recommended for children younger than two years of age. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Leuprolyn Depot 3.75 mg Injection 1's, let your doctor know if you have liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Leuprolyn Depot 3.75 mg Injection 1's may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Leuprolyn Depot 3.75 mg Injection 1's. Leuprolyn Depot 3.75 mg Injection 1's can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.